—While MRI can detect abnormal atrophy during preclinical Alzheimer’s disease, atrophy assessment should be tailored to the targeted disease stage and intended use. Structural magnetic resonance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results